<?xml version="1.0" encoding="UTF-8"?><!DOCTYPE us-patent-application SYSTEM "us-patent-application-v43-2012-12-04.dtd" [ ]><us-patent-application lang="EN" dtd-version="v4.3 2012-12-04" file="US20140006315A1-20140102.XML" status="PRODUCTION" id="us-patent-application" country="US" date-produced="20131218" date-publ="20140102"><us-bibliographic-data-application lang="EN" country="US"><publication-reference><document-id><country>US</country><doc-number>20140006315</doc-number><kind>A1</kind><date>20140102</date></document-id></publication-reference><application-reference appl-type="utility"><document-id><country>US</country><doc-number>13539575</doc-number><date>20120702</date></document-id></application-reference><us-application-series-code>13</us-application-series-code><classifications-ipcr><classification-ipcr><ipc-version-indicator><date>20060101</date></ipc-version-indicator><classification-level>A</classification-level><section>G</section><class>06</class><subclass>Q</subclass><main-group>90</main-group><subgroup>00</subgroup><symbol-position>F</symbol-position><classification-value>I</classification-value><action-date><date>20140102</date></action-date><generating-office><country>US</country></generating-office><classification-status>B</classification-status><classification-data-source>H</classification-data-source></classification-ipcr></classifications-ipcr><classifications-cpc><main-cpc><classification-cpc><cpc-version-indicator><date>20130101</date></cpc-version-indicator><section>G</section><class>06</class><subclass>Q</subclass><main-group>90</main-group><subgroup>00</subgroup><symbol-position>F</symbol-position><classification-value>I</classification-value><action-date><date>20140102</date></action-date><generating-office><country>US</country></generating-office><classification-status>B</classification-status><classification-data-source>H</classification-data-source><scheme-origination-code>C</scheme-origination-code></classification-cpc></main-cpc></classifications-cpc><classification-national><country>US</country><main-classification>705500</main-classification></classification-national><invention-title id="d0e43">METHOD OF MARKETING OREGANO CAPSULES CONTAINING THYMOQUINONE</invention-title><us-parties><us-applicants><us-applicant sequence="00" app-type="applicant" designation="us-only"><addressbook><last-name>Etheve</last-name><first-name>St&#xe8;phane</first-name><address><city>Basel</city><country>CH</country></address></addressbook><residence><country>CH</country></residence></us-applicant><us-applicant sequence="01" app-type="applicant" designation="us-only"><addressbook><last-name>PRUDENCE</last-name><first-name>Kevin</first-name><address><city>Basel</city><country>CH</country></address></addressbook><residence><country>CH</country></residence></us-applicant><us-applicant sequence="02" app-type="applicant" designation="us-only"><addressbook><last-name>SCHWEIKERT</last-name><first-name>Loni</first-name><address><city>Basel</city><country>CH</country></address></addressbook><residence><country>CH</country></residence></us-applicant><us-applicant sequence="03" app-type="applicant" designation="us-only"><addressbook><last-name>Szepes</last-name><first-name>Aniko</first-name><address><city>Basel</city><country>CH</country></address></addressbook><residence><country>CH</country></residence></us-applicant></us-applicants><inventors><inventor sequence="00" designation="us-only"><addressbook><last-name>Etheve</last-name><first-name>St&#xe8;phane</first-name><address><city>Basel</city><country>CH</country></address></addressbook></inventor><inventor sequence="01" designation="us-only"><addressbook><last-name>PRUDENCE</last-name><first-name>Kevin</first-name><address><city>Basel</city><country>CH</country></address></addressbook></inventor><inventor sequence="02" designation="us-only"><addressbook><last-name>SCHWEIKERT</last-name><first-name>Loni</first-name><address><city>Basel</city><country>CH</country></address></addressbook></inventor><inventor sequence="03" designation="us-only"><addressbook><last-name>Szepes</last-name><first-name>Aniko</first-name><address><city>Basel</city><country>CH</country></address></addressbook></inventor></inventors></us-parties></us-bibliographic-data-application><abstract id="abstract"><p id="p-0001" num="0000">This invention relates to a method of marketing capsule formulations for pharmaceutical, nutraceuticals or food supplements which contain oregano oil containing thymoquinone (THQ) as an active ingredient at a concentration of least 2 weight % and which can be stored at room temperature. The capsules have a hydroxypropylmethylcellulose (HPMC) shell and may contain carvacrol (CRV) as an additional active ingredient, either in synthetic form, or as part of a plant extract. Optionally, the capsules may contain a viscosity agent. The method includes the steps of advising a potential consumer of the benefits of THQ, and optionally CRV and providing a kit containing these capsules.</p></abstract></us-patent-application>